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OpinionGlossary
3Rs (reduction, refinement, and replacement): an ethical framework for the use
and care of animals in scientific experiments. This includes the replacement of
animals wherever possible, the refinement of husbandry and procedures
during experiments, and the reduction in terms of improving approaches and
increasing efficiency of experiments [45,46].
Clustered regularly interspaced short palindromic repeats/CRISPR-associated
9 system (CRISPR/Cas9 system): a system used by prokaryotes for immuniza-
tion processes by integrating exogenous DNA to keep track of viral attacks and
to defend their organism from invaders with similar DNA. New technologies
now allow for the transfer of this system to eukaryotes. Customized Cas9
nucleases are guided by small RNAs to the target site in the genome to
manipulate specific genes [41,44,47].
Genome-wide association studies (GWAS): identification of SNPs in the
genome and analysis of their distribution in different (phenotypic) populations.
Based on these data associations between specific SNPs and disorders,
physiological traits or gene functions can be detected [48].
Personalized medicine: based on genomic information from individuals and
patients, associations between genes and diseases are detected and used for
personalized marker-assisted diagnosis, prevention, and treatment [49,50].The success of personalized medicine rests on under-
standing the genetic variation between individuals.
Thus, as medical practice evolves and variation among
individuals becomes a fundamental aspect of clinical
medicine, a thorough consideration of the genetic and
genomic information concerning the animals used as
models in biomedical research also becomes critical. In
particular, nonhuman primates (NHPs) offer great prom-
ise as models for many aspects of human health and
disease. These are outbred species exhibiting substan-
tial levels of genetic variation; however, understanding
of the contribution of this variation to phenotypes is
lagging behind in NHP species. Thus, there is a pivotal
need to address this gap and define strategies for char-
acterizing both genomic content and variability within
primate models of human disease. Here, we discuss the
current state of genomics of NHP models and offer
guidelines for future work to ensure continued improve-
ment and utility of this line of biomedical research.
The need to advance understanding of nonhuman
primate genomes
With the accelerating development of whole-genome se-
quencing techniques and related methods, such as high-
throughput genotyping and whole-exome (re)sequencing
(WES; see Glossary), personalized medicine is no longer
just a visionary goal in human medicine. Currently, knowl-
edge of the patient’s genotype can aid in the selection of
targeted drugs or special therapeutic treatments; cancer
research and treatment have shown early successes in0168-9525/
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482 Trends in Genetics, November 2014, Vol. 30, No. 11this regard [1,2]. Given this recent progress, with more
anticipated soon, there is a critical need to interpret and
apply the results of animal-derived disease modeling and
drug safety or efficacy testing within the framework of
individual human genetic and genomic variation. To
achieve this, ideally, the same extent of information re-
garding genetic background should be available for both
the patient population and the preclinical animal model.
Information on genetic variation among individuals is
particularly important for NHPs, which are widely used as
model organisms in biomedical research. For most of these
primate models, there is clear evidence of biologically
meaningful genetic differences among species and, as withTranscription activator-like effector nucleases (TALENs): genome-editing tool
using nucleases that are fused to a DNA-binding module, which can be
customized for sequence-specific targets [51].
Whole-exome (re-)sequencing (WES): technology of next-generation sequen-
cing to determine all variants of known coding regions (exons) in the genome
[52]. Available genome sequences provide reference genomes for comparative
sequencing or resequencing technologies, which are used to identify muta-
tions and polymorphisms between organisms.
Opinion Trends in Genetics November 2014, Vol. 30, No. 11humans, substantial levels of genetic variability within
species frequently linked to geographical origin [3–6].
Although there is evidence that the genomic makeup of
NHPs can have considerable influence on the outcome of
biomedical experiments [7–12], the number of detailed
genetic studies accounting for these differences is still
low compared with the total number of biomedical studies
conducted with NHPs.
Accordingly, for the broad scientific and industrial com-
munity using NHP models, some fundamental guidelines
are needed on how to apply successfully modern genomic
tools to NHP research. We argue that there is an urgent
need to increase the number of sequenced NHP genomes,
as well as of studies investigating the influence of genetic
variation on experimental outcomes. Furthermore, re-
search would benefit from improved knowledge of biomark-
ers for disease, genetic disorders, and toxicology, as well as
of the respective differences between human and NHP
genomes. Here, we highlight some of the most important
aspects that should be considered to direct future devel-
opments and strategies for primate genetics in modern
biomedical research.
Genetic variation in NHP models and its relevance to
biomedical research
NHPs, such as macaques (Macaca spp.), baboons (Papio
spp.), African green monkeys (Chlorocebus spp.), and the
common marmoset (Callithrix jacchus), are commonly used
as models in biomedical and pharmacological experiments
and during preclinical safety assessments. Based on phylo-
genetic studies using single or multilocus approaches, re-
markable genetic variation has been found to occur not only
between species, but also between populations of the same
species from different geographic origins (Box 1). This is
especially important because native geographic origins of
test animals from commercial breeding centers are often
unknown or, at best, uncertain. For example, cynomolgus
macaques (Macaca fascicularis) exported from China,
where they do not occur naturally (see Figure I in Box 1),
originate from various countries in Asia [13,14]. In addition
to the inherent inter- and intraspecific variation, in many of
these NHP models, past interspecific hybridization has led
to even more complex mosaic genomes, which comprise
patches of different species ancestry (Box 1). Moreover, a
comparative analysis of rhesus macaque and human genetic
variation found that the rhesus macaque is three times as
diverse as humans [15]. This high level of within-species
diversity is a fundamental biological parameter that is an
important consideration for any scientific study of rhesus
macaques, which are commonly used as models for human
disease. Evidence from mitochondrial DNA and other stud-
ies suggest that rhesus macaques are not unusual in having
large amounts of genetic variation, and that high levels of
variability are typical for NHPs [16].
Although relatively few studies have explicitly analyzed
the genetic variation of experimental animals, there is
increasing evidence that the genomic makeup of NHP
models can considerably affect the outcome of biomedical
experiments. This has been observed when animals from
different populations (i.e., from different geographic
regions) or unrecognized hybrids are used within oneexperimental approach. For example, in simian or human
immunodeficiency virus (SIV/HIV) research, primate ge-
netic variation can affect viral replication as well as the
control of an infection [17–23]. Moreover, an acquired
immune deficiency syndrome (AIDS)-like state similar to
that seen in humans is primarily developed in rhesus
macaques (Macaca mulatta) of Indian origin, whereas a
more moderate disease progression is typical in rhesus
macaques of Chinese origin [21,24]. Given these observa-
tions, it has become routine to genotype loci that are known
to influence SIV/HIV disease progression, such as tripar-
tite motif-containing protein 5 (TRIM5) or major histocom-
patibility complex (MHC) genes. Based on these data,
research subjects and study groups are screened for genetic
characteristics and chosen depending on those results
before any SIV/HIV study [7,20,25].
Genetic divergence also affects physiological traits.
Cynomolgus macaques of Mauritian origin are known to
develop faster and to achieve sexual maturity earlier than
cynomolgus macaques of Asian mainland origin [26]. In a
vaccine study, cynomolgus macaques from Mauritius
responded differently to Shigella immunization compared
with cynomolgus macaques from non-Mauritian origins.
Mauritian animals did not develop clinical shigellosis be-
cause of distinct gut microbiota [27]. These examples
underline the advantages of knowing the geographic origin
and genetic background of potential study subjects, before
beginning any experiments. However, more importantly,
even individual variation is known to influence disease
susceptibilities and other disorders. In an experiment
testing behavioral and neurobiological reactivity to a brief
mild stress, rhesus macaques of a single family pedigree
showed individual phenotypic variation that correlated
with DNA sequence variation in the corticotrophin-releas-
ing hormone receptor 1 gene (CRHR1), which is associated
with the diathesis for anxiety and depression in humans
[10]. A similar influence of genetic variation has been
reported for other diseases, such as malaria susceptibility
[8], and for toxicology studies [28]. For additional exam-
ples, readers are referred to a basic overview recently
provided in a 2013 special issue of the ILAR Journal
entitled ‘Progress in Genetics and Genomics of Nonhuman
Primates’, dedicated to the topic of future trends in geno-
mics of NHP models and its importance for biomedical
research, including aspects of genetic variation in NHPs
(for an outline, see [29]).
These examples highlight the importance of under-
standing genetic variation within NHPs and its relevance
to toxicology, physiology, and human disease models. Re-
cently, investigators have suggested that ‘differences be-
tween species, ultimately arising at the genetic level, must
be considered for informed research approaches’ [30]. For
many study designs, it is prudent to know whether inter- or
intraspecific differences occur, the significance of these
differences, and if they can be controlled for. From a
practical standpoint, several questions arise: what is the
best way to obtain relevant genetic data for potential
research subjects, how many data and what type are
required to design a given experiment effectively, and
how should this information be incorporated into future
study designs or selection of test animals? These483
Box 1. Genetic variation and hybridization in nonhuman primate models
Several of the NHP models have wide geographic distributions,
including macaques mainly on the Asian continent, and baboons and
African green monkeys in Africa. Given the wide geographic range
and reduced or absent gene flow between populations, different
(sub)species of these genera exhibit notable genetic and sometimes
even phenotypical and/or behavioral variation [4–6,53,54]. SNPs
clearly differentiate rhesus macaques from India and China
[3,34,55]. Similarly, a SNP analysis of cynomolgus macaques
identified several polymorphisms unique to geographical populations
of cynomolgus macaques from Indonesia and Indochina despite
unrecognized phenotypic differences [14].
Moreover, there is evidence for ancient and ongoing intrageneric
hybridization between most species of these genera in areas where
their ranges meet [6,12,56–59]. Continuing hybridization over genera-
tions may lead to the transfer of certain genes into the genome of
another species, a process called ‘introgression’. In some cases, this
can even cause genome-wide admixture of involved species, leading
to a mosaic genome [60–62].
For example, the genome of cynomolgus macaques from the Asian
mainland, north of the Isthmus of Kra, is introgressed by rhesus
macaques (Figure I). Studies using Y chromosomal and mitochondrial
markers revealed that Asian mainland cynomolgus macaques carry Y
chromosomal fragments of rhesus macaques from China and
Myanmar, but not from India, whereas they retained their original
cynomolgus macaque mitochondrial genome [5,58]. A recent genome
analysis [12] showed that up to approximately 30% of the genome of
Asian mainland cynomolgus macaques is of rhesus macaque origin.
Given that most cynomolgus macaques used in biomedical research
are derived from breeding centers in China and Vietnam, it is obvious
that these animals are likely not pure cynomolgus macaques [63,64].
Likewise, although presumably not introgressed by rhesus macaques,
cynomolgus macaques imported from Indonesia and the Philippines
are genetically highly diverse [5,65], which is unsurprising consider-
ing the wide distribution of the species and the isolation of certain
island populations (Figure I). In addition, Mauritian cynomolgus
macaques, which most likely originated from a few Indonesian
founder animals and, hence, are thought to be relatively homo-
geneous, carry a combination of insular mitochondrial DNA and
continental Y chromosomal DNA [5]. Thus, cynomolgus macaques
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Figure I. Natural distribution of rhesus (Macaca mulatta) and cynomolgus (Macaca fascicularis) macaques. The hatched region indicates the putative area of
introgression from rhesus into cynomolgus macaques. Adapted from [14,63].
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management, primate husbandry, and animal welfare.
Below, we discuss potential solutions to these challenges
and suggest guidelines for the field to adopt.
Applications of NHP genomics to biomedical research
In the era of affordable whole-genome sequencing, obtain-
ing detailed information about the genetic makeup of
NHPs is relatively straightforward. The genomes of sever-
al NHP species have now been sequenced in addition to
those of the great apes, which were published within the
past few years [9,16]. Whole-genome sequences (WGS) are
now available for a Mauritian, Malaysian, and a reported
Asian mainland cynomolgus macaque [12,28,31], for four
Indian and two Chinese rhesus macaques [3,32–34], and
for one Tibetan macaque (Macaca thibetana) [35]. WGS of
other macaque species, as well as of baboons, African green
monkeys, and marmosets, are in progress [16,36,37]. These
data provide an important basis for understanding physi-
ological characteristics and their underlying genetic causes
(e.g., [38]). More importantly, however, these genome
sequences facilitate high-resolution genotyping and rese-
quencing of other individuals [28,39]. Thus, the fundamen-
tal tools are in place to expand understanding of individual
NHP genetic variation. Comparisons of the few available
WGS of rhesus and cynomolgus macaques from different
populations are valuable examples of the power of genome
sequencing [3]. However, due to the known inter- and
intraspecies genetic variation in NHP models, in our opin-
ion these examples provide only a glimpse of the potential
of genome typing. To reduce the genetic ‘noise’ in biomedi-
cal studies, we need more complete and better-annotated
reference genomes for animals from diverse geographic
areas to be able to select individuals with appropriate
genetic backgrounds for a single study. Given the striking
differences in physiology, drug metabolism, and disease
susceptibilities between cynomolgus and rhesus maca-
ques, we also recommend the inclusion of several individ-
uals from the Asian mainland introgression zone into WGS
projects (see Figure I in Box 1). Although one approach is to
determine whether significant genomic regions, relevant to
the experiment, are affected by introgression, or whether
they correspond to the phenotypical species, we also need
information on the extent of introgression in the complete
genomes of our study animals to estimate the influence of
potential ‘foreign’ genetic material. Until we understand
the implications of this admixture for various types of
research projects, it is difficult to determine an ‘acceptable’
level of admixture, but such a threshold analysis would be
useful.
To identify loci and alleles that are associated with
specific physiological traits, differences in gene expression
and/or disease risk, or which alter the rate of drug metabo-
lism, we require more informed genome-wide association
studies (GWAS). Although this is far from being a reality,
we suggest establishing data banks of well-annotated WGS
for significant populations of known geographic origin and
for major breeding lineages of each NHP model species.
With these reference data, it might be sufficient to charac-
terize the geographic origin using only a few specific loci
before experiments in future study designs. For suchapproaches, the analysis of single nucleotide polymor-
phisms (SNPs) might be one promising tool. In macaques,
SNP analyses can already assist in determining geograph-
ic origins of animals imported from breeding centers and in
the genetic-based selection of animals before experiments
[14,35,40]. Additional typing of specific genomic regions,
which are known to be associated with respective diseases
or physiologies, will then further assist pre-selection of
animals and help to minimize false results in experiments
and to improve the reliability of biomedical studies.
Furthermore, with the advances in personalized medi-
cine, there is the crucial need to expand our knowledge of
differences between human and NHP genomes and to
determine how they can affect the usage of NHPs to model
human disease and drug responses reliably. Comprehen-
sive comparisons of WGS of humans and NHP models, in
combination with results of GWAS, will enable us to detect
coding variations and similarities and, thus, also increase
our ability to detect true causal relations between genotype
and disease, and their influence on biomedical studies.
Another promising tool in NHP research is the produc-
tion of genetically modified primates for targeted
approaches. Different methods are being developed, and
the most promising are currently the nuclease-based clus-
tered regularly interspaced short palindromic repeats
(CRISPR)/CRISPR-associated 9 (CRISPR/Cas9) system
[41] and transcription activator-like effector nucleases
(TALEN)-based gene modification [42]. Nucleases can be
programmed to target specific sites in the genome, and to
mutate or knock out genes, or alter their expression
[43,44]. With these tools, NHPs can be efficiently used to
model human diseases and to develop therapies for genetic
disorders. However, as a basis for the usage of transgenic
monkeys in biomedical research and personalized medi-
cine, we need more information regarding gene functions
and possible markers for toxicology and disease in both
human and primate genomes.
Incorporating NHP genomics into breeding
management and primate husbandry
As high-throughput sequencing techniques become signif-
icantly cheaper, new opportunities will arise because many
institutions, pharmacological industries, and breeding fa-
cilities are essentially driven by cost efficiency. However, it
is not yet clear whether sequencing and the associated data
analysis burden will become affordable enough for the
majority of these institutions and facilities to genotype
multiple individuals of each primate species used in their
facility. Therefore, although the value of whole-genome
analyses in NHP models is without doubt, questions arise
concerning how breeders, academia, and industry should
prioritize these resources and how the financial and prac-
tical challenges of implementing the use of genetically
well-characterized NHP models can be met.
Genomic information can be used to select certain gen-
otypes for specific experimental approaches, which is
expected to increase the accuracy and efficiency of scientific
studies, as well as to decrease the number of test animals
used. Although such approaches can contribute in substan-
tial and practical ways to achieve reduction and refinement
within the principles of the 3Rs (reduction, refinement,485
Opinion Trends in Genetics November 2014, Vol. 30, No. 11and replacement), new problems might arise for breeding
facilities and researchers. The development of a geno-
type-based selection method of test animals would lead to
specific requests for particular subsets of animals or
animals from specific geographic regions depending on
the research question. For a market that is already
increasingly led and, thus, also restricted, by national
and international laws and directives on the usage of
animals in experimental approaches, it is questionable
whether such a selective approach is practical in all
facilities. Moreover, the relatively long generation times
of NHPs, difficulties in sperm collection and artificial
insemination, as well as increasing efforts to improve
primate husbandry and welfare, make implementation of
selective breeding to enrich certain genotypes based on
genomic data nontrivial. Finally, selective breeding for
one set of genotypes today severely limits the future
genetic potential of research and breeding populations,
essentially locking in the current research interests and
causing undesirable reduction in total genetic variability.
Thus, the maintenance of genetic diversity within facili-
ties has to be balanced with the need for selectively bred
lines of NHPs. The dangers of overselection are real and
must be avoided.
As a first step, in line with advances in NHP genomics,
breeding centers and primate facilities should begin to pay
more attention to separate and maintain populations from
specific geographic regions, well-characterized breeding
lineages, and groups that include introgressed or admixed
individuals. As a long-term goal, it is possible that addi-
tional selectively bred lines could be established for major
disease models to enable a genome-based selection of
specific genotypes. However, this should only be done after
careful consideration of the near- and long-term conse-
quences, and when it will further refine NHP research
and take advantage of other advances in personalized
medicine.
Concluding remarks
More genomic information about within-species variation
as well as between-species differences is required. One
promising approach is to sequence whole genomes from
sets of representative lineages within species from known
geographic origins. As the cost of sequencing continues to
decline, it will become feasible to analyze WGS on a
population genetic scale [3,12,34]. In addition, we also
recommend increasing effort be made in GWAS and other
types of studies that explicitly test for potential influences
of genetic variation in NHP models on biomedical experi-
ments. Comparisons of these data with results from anno-
tated human genomes will substantially increase
knowledge on gene functions and enable us to reduce
genetic background noise in both human and NHP studies.
Moreover, such results will provide essential information
for the application of transgenic primates in biomedical
research and advance their usage in personalized medi-
cine. With respect to primate husbandry and selective
breeding, an overall approach that maximizes the genetic
value of animals today while maintaining maximum flexi-
bility and genetic potential for the future must be primary
goals.486Acknowledgments
We are grateful to two anonymous reviewers for their constructive
comments, which substantially improved the manuscript. Part of this
work has been supported by EUPRIM-Net under the EU grant agreement
262443 of the 7th Framework Programme.
References
1 Simon, R. and Roychowdhury, S. (2013) Implementing personalized
cancer genomics in clinical trials. Nat. Rev. Drug Discov. 12, 358–369
2 Workman, P. et al. (2013) Genome-based cancer therapeutics: targets,
kinase drug resistance and future strategies for precision oncology.
Curr. Opin. Pharmacol. 13, 486–496
3 Fawcett, G.L. et al. (2011) Characterization of single-nucleotide
variation in Indian-origin rhesus macaques (Macaca mulatta). BMC
Genomics 12, 311
4 Haus, T. et al. (2013) Mitochondrial diversity and distribution of
African green monkeys (Chlorocebus Gray, 1870). Am. J. Primatol.
75, 350–360
5 Tosi, A.J. and Coke, C.S. (2007) Comparative phylogenetics offer new
insights into the biogeographic history of Macaca fascicularis and the
origin of the Mauritian macaques. Mol. Phylogenet. Evol. 42, 498–504
6 Zinner, D. et al. (2009) Mitochondrial phylogeography of baboons
(Papio spp.): indication for introgressive hybridization? BMC Evol.
Biol. 9, 83
7 de Groot, N.G. et al. (2011) TRIM5 allelic polymorphism in macaque
species/populations of different geographic origins: its impact on SIV
vaccine studies. Tissue Antigens 78, 256–262
8 Flynn, S. et al. (2009) Genetic variation at the TNF-alpha promotor and
malaria susceptibility in rhesus (Macaca mulatta) and long-tailed
(Macaca fascicularis) macaques. Infect. Genet. Evol. 9, 769–777
9 Rogers, J. (2013) In transition: primate genomics at a time of rapid
change. ILAR J. 54, 224–233
10 Rogers, J. et al. (2013) CRHR1 genotypes, neural circuits and the
diathesis for anxiety and depression. Mol. Psychiatry 18, 700–707
11 Vinson, A. et al. (2013) The value of extended pedigrees for next-
generation analysis of complex disease in the rhesus macaque. ILAR
J. 54, 91–105
12 Yan, G. et al. (2011) Genome sequencing and comparison of two
nonhuman primate animal models, the cynomolgus and Chinese
rhesus macaques. Nat. Biotechnol. 29, 1019–1025
13 Hsu, C.K. (2011) China as a resource for NHP. In Animal Research in a
Global Environment: Meeting the Challenges (Institute for Laboratory
Animal Research, Division on Earth and Life Studies), pp. 224–227,
National Academies Press
14 Street, S.L. et al. (2007) Single nucleotide polymorphisms (SNPs) are
highly conserved in rhesus (Macaca mulatta) and cynomolgus (Macaca
fascicularis) macaques. BMC Genomics 8, 480
15 Yuan, Q. et al. (2012) The rhesus macaque is three times as diverse but
more closely equivalent in damaging coding variation as compared to
the human. BMC Genet. 13, 52
16 Rogers, J. and Gibbs, R. (2014) Comparative primate genomics:
emerging patterns of genome content and dynamics. Nat. Rev.
Genet. 15, 347–359
17 Mee, E.T. et al. (2009) MHC haplotype frequencies in a UK breeding
colony of Mauritian cynomolgus macaques mirror those found in a
distinct population from the same geographic origin. J. Med. Primatol.
38, 1–14
18 Giraldo-Vela, J.P. et al. (2008) The major histocompatibility complex
class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a
cohort of simian immunodeficiency virus-infected rhesus macaque elite
controllers. J. Virol. 82, 859–870
19 Lim, S-Y. et al. (2010) TRIM5a modulates immunodeficiency virus
control in rhesus monkeys. PLoS Pathog. 6, e1000738
20 Kirmaier, A. et al. (2010) TRIM5 suppresses cross-species transmission
of a primate immunodeficiency virus and selects for emergence of
resistant variants in the new species. PLoS Biol. 8, e1000462
21 Reimann, K.A. et al. (2005) Pathogenicity of simian-human
immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in
cynomolgus macaques and associated with early T-lymphocyte
responses. J. Virol. 79, 8878–8885
22 Mee, E.T. et al. (2010) Mhc haplotype M3 is associated with early
control of SHIVsbg infection in Mauritian cynomolgus macaques.
Tissue Antigens 76, 223–229
Opinion Trends in Genetics November 2014, Vol. 30, No. 1123 Florese, R.H. et al. (2008) Comparative study of Tat vaccine regimes in
Mauritian cynomolgus and Indian rhesus macaques: influence of
Mauritian MHC haplotypes on susceptibility/resistance to
SHIV89.6P infection. Vaccine 26, 3312–3321
24 Trichel, A.M. et al. (2002) Species-specific variation in SIV disease
progression between Chinese and Indian subspecies of rhesus
macaque. J. Med. Primatol. 31, 171–178
25 Doxiadis, G.G.M. et al. (2003) Evolutionary stability of MHC class II
haplotypes in diverse rhesus macaque populations. Immunogenetics
55, 540–551
26 Luetjens, C.M. and Weinbauer, G.F. (2012) Functional assessment of
sexual maturity in male macaques (Macaca fascicularis). Regul.
Toxicol. Pharmacol. 63, 391–400
27 Seekatz, A.M. et al. (2013) Differential response of the cynomolgus
macaque gut microbiota to Shigella infection. PLoS ONE 8, e64212
28 Ebeling, M. et al. (2011) Genome-based analysis of the nonhuman
primate Macaca fascicularis as a model for drug safety assessment.
Genome Res. 21, 1746–1756
29 Harding, J.D. (2013) Progress in genetics and genomics of nonhuman
primates. ILAR J. 54, 77–81
30 Vallender, E.J. and Miller, G.M. (2013) Nonhuman primate models in
the genomic era: a paradigm shift. ILAR J. 54, 154–165
31 Higashino, A. et al. (2012) Whole-genome sequencing and analysis of
the Malaysian cynomolgus macaque (Macaca fascicularis) genome.
Genome Biol. 13, R58
32 Fang, X. et al. (2011) Genome sequence and global sequence variation
map with 5.5 million SNPs in Chinese rhesus macaque. Genome Biol.
12, R63
33 Gibbs, R.A. et al. (2007) Evolutionary and biomedical insights from the
rhesus macaque genome. Science 316, 222–234
34 Hernandez, R.D. et al. (2007) Demographic histories and patterns of
linkage disequilibrium in Chinese and Indian rhesus macaques.
Science 316, 240–243
35 Fan, Z. et al. (2014) Whole genome sequencing of Tibetan macaque
(Macaca thibetana) provides new insight into the macaque
evolutionary history. Mol. Biol. Evol. http://dx.doi.org/10.1093/
molbev/msu104
36 Bosinger, S.E. et al. (2011) Primate genomes for biomedicine. Nat.
Biotechnol. 29, 983–984
37 Worley, K.C. and the Marmoset Genome Sequencing Consortium. The
common marmoset genome provides insight into primate biology and
evolution. Nat. Genet. (in press)
38 Harris, R.A. et al. (2014) Evolutionary genetics and implications of
small size and twinning in callitrichine primates. Proc. Natl. Acad. Sci.
U.S.A. 111, 1467–1472
39 Vallender, E.J. (2011) Expanding whole exome resequencing into non-
human primates. Genome Biol. 12, R87
40 Kanthaswamy, S. et al. Development and validation of a SNP-based
assay for inferring the genetic ancestry of rhesus macaques (Macaca
mulatta). Am. J. Primatol. (in press)
41 Niu, Y. et al. (2014) Generation of gene-modified cynomolgus monkey
via Cas9/RNA-mediated gene targeting in one-cell embryos. Cell 156,
836–843
42 Liu, H. et al. (2014) TALEN-mediated gene mutagenesis in rhesus and
cynomolgus monkeys. Cell Stem Cell 14, 323–328
43 Gaj, T. et al. (2013) ZFN, TALEN, CRISPR/Cas-based methods for
genome engineering. Trends Biotechnol. 31, 397–405
44 Sander, J.D. and Joung, J.K. (2014) CRISPR-Cas systems for editing,
regulating and targeting genomes. Nat. Biotechnol. 32, 347–35545 Guhad, F. (2005) Introduction to the 3Rs (refinement, reduction and
replacement). Contemp. Top. Lab. Anim. Sci. 44, 58–59
46 Wells, D.J. (2011) Animal welfare and the 3Rs in European biomedical
research. Ann. N. Y. Acad. Sci. 1245, 14–16
47 Horvath, P. and Barrangou, R. (2010) CRISPR/Cas, the immune
system of bacteria and Archaea. Science 327, 167–170
48 Norrgard, K. (2014) Genetic variation and disease: GWAS. Nat. Educ.
1, 87
49 Ginsburg, G.S. and McCarthy, J.J. (2001) Personalized medicine:
revolutionizing drug discovery and patient care. Trends Biotechnol.
19, 491–496
50 Katsios, C. and Roukos, D.H. (2010) Individual genomes and
personalized medicine: life diversity and complexity. Per. Med. 7,
347–350
51 Joung, J.K. and Sander, J.D. (2013) TALENs: a widely applicable
technology for targeted genome editing. Nat. Rev. Mol. Cell Biol. 14,
49–55
52 Rabbani, B. et al. (2014) The promise of whole-exome sequencing in
medical genetics. J. Hum. Genet. 59, 5–15
53 Melnick, D.J. et al. (1993) mtDNA diversity in rhesus monkeys reveals
overestimates of divergence time and paraphyly with neighboring
species. Mol. Biol. Evol. 10, 282–295
54 Smith, D.G. (2005) Genetic characterization of Indian-origin and
Chinese-origin rhesus macaques (Macaca mulatta). Comp. Med. 55,
227–230
55 Ferguson, B. et al. (2007) Single nucleotide polymorphisms (SNPs)
distinguish Indian-origin and Chinese-origin rhesus macaques
(Macaca mulatta). BMC Genomics 8, 43
56 Bonhomme, M. et al. (2009) Assessing natural introgression in 2
biomedical model species, the rhesus macaque (Macaca mulatta)
and the long-tailed macaque (Macaca fascicularis). J. Hered. 100,
158–169
57 Haus, T. et al. (2013) Discordance between spatial distributions of Y-
chromosomal and mitochondrial haplotypes in African green monkeys
(Chlorocebus spp.): a result of introgressive hybridization or cryptic
diversity? Int. J. Primatol. 34, 986–999
58 Tosi, A.J. et al. (2003) Paternal, maternal, and biparental molecular
markers provide unique windows onto the evolutionary history of
macaque monkeys. Evolution 57, 1419–1435
59 Jolly, C.J. et al. (2011) Kinda baboons and grayfoot chacma baboons
hybridize in the Kafue River valley Zambia. Am. J. Primatol. 73, 291–303
60 Arnold, M.L. and Meyer, A. (2006) Natural hybridization in primates:
one evolutionary mechanism. Zoology 109, 261–276
61 Roos, C. et al. (2011) Natural hybridization in primates. In Future
Trends in Primate Toxicology and Biotechnology (Weinbauer, G.F. and
Vogel, F., eds), pp. 9–33, Waxmann
62 Zinner, D. et al. (2011) The strange blood: natural hybridization in
primates. Evol. Anthropol. 20, 96–103
63 Roos, C. and Zinner, D. Diversity and evolutionary history of macaques
with special focus on rhesus and long-tailed macaques. In The
Nonhuman Primate in Nonclinical Drug Development and Safety
Assessment (Blu¨ mel, J. et al., eds), Elsevier (in press)
64 Stevison, L.S. and Kohn, M.H. (2009) Divergence population genetic
analysis of hybridization between rhesus and cynomolgus macaques.
Mol. Ecol. 18, 2457–2475
65 Smith, D.G. et al. (2007) Mitochondrial DNA variation within and
among regional populations of longtail macaques (Macaca fascicularis)
in relation to other species of the fascicularis group of macaques. Am. J.
Primatol. 69, 182–198487
